|
C12ORF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.937600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.831200E-01 |
| Normal-vs-Stage2 |
5.123200E-01 |
| Normal-vs-Stage3 |
6.120800E-01 |
| Normal-vs-Stage4 |
9.773800E-01 |
| Stage1-vs-Stage2 |
7.240600E-01 |
| Stage1-vs-Stage3 |
8.032400E-01 |
| Stage1-vs-Stage4 |
8.290000E-01 |
| Stage2-vs-Stage3 |
9.089200E-01 |
| Stage2-vs-Stage4 |
6.681600E-01 |
| Stage3-vs-Stage4 |
7.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.631400E-01 |
| Normal-vs-AfricanAmerican |
1.906170E-01 |
| Normal-vs-Asian |
4.350200E-01 |
| Caucasian-vs-AfricanAmerican |
4.068000E-01 |
| Caucasian-vs-Asian |
7.640600E-01 |
| AfricanAmerican-vs-Asian |
9.920200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.073000E-01 |
| Normal-vs-Female |
5.274300E-02 |
| Male-vs-Female |
5.766400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.951200E-01 |
| Normal-vs-Extreme_Weight |
7.360000E-01 |
| Normal-vs-Obese |
2.747400E-01 |
| Normal-vs-Extreme_Obese |
2.087000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.642200E-01 |
| Normal_Weight-vs-Obese |
8.900300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.102800E-01 |
| Extreme_Weight-vs-Obese |
1.060380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.472400E-01 |
| Obese-vs-Extreme_Obese |
1.230970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.659400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.019390E-01 |
| Normal-vs-Age(61-80Yrs) |
8.670400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.648300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.216780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.568180E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.776000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.580200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923950E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.834000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.260400E-01 |
| Normal-VS-Type2 PRCC |
5.407800E-01 |
| Normal-VS-KIRP CIMP |
5.319400E-01 |
| Normal-VS-Unclassified PRCC |
4.888000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.048300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.168600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.410040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.019000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.139500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.228600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.486200E-01 |
| Normal-vs-N1 |
9.232500E-02 |
| Normal-vs-N2 |
7.221600E-01 |
| N0-vs-N1 |
6.874200E-02 |
| N0-vs-N2 |
6.989200E-01 |
| N1-vs-N2 |
2.953800E-01 |
|
|
